One size fits all: The semi-synthesis of new undecaprenol analogues for the study of multiple undecaprenyl-processing enzymes
One size fits all: The semi-synthesis of new undecaprenol analogues for the study of multiple undecaprenyl-processing enzymes
批准号:
EP/S015892/1
负责人:
Stephen Cochrane
金额:
$27.5万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --
中文摘要
抗菌素耐药性是对人类健康的主要威胁,因此有必要寻找新的抗菌素靶标。细菌产生几种对其生存至关重要的糖共聚物,包括肽聚糖,这是结构完整性所需的细菌细胞壁的关键成分。细菌细胞壁是许多临床使用的抗生素的靶标,如青霉素和万古霉素。糖共聚物的生物合成涉及几个关键的糖脂中间体,所有这些中间体都通过十一烯醇分子连接到细胞膜上。处理与十一烯醇连接的生物分子的酶是抗生素的热门目标,因为它们是细菌特有的。然而,由于缺乏合适的探针来监测它们的活性,对这些酶的详细研究和高通量筛选可能的抑制剂一直受到限制。了解酶的作用机制是合理设计抑制剂的重要前提。该项目旨在开发新的十一烯醇标记类似物,将用于研究几种新的抗生素靶标,并为高通量筛选潜在的抗生素候选者提供一种方法。
英文摘要
Antibacterial resistance is a major threat to human health and there is a pertinent need for new antimicrobial targets. Bacteria produce several glycopolymers that are vital to their survival, including peptidoglycan, which is a key component of the bacterial cell wall required for structural integrity. The bacterial cell wall is targeted by many clinically used antibiotics, such as penicillin and vancomycin. Glycopolymer biosynthesis involves several key glycolipid intermediates, all of which are linked to the cell membrane by the molecule undecaprenol. The enzymes that process undecaprenol-linked biomolecules are hot antibiotic targets, as they are unique to bacteria. However, detailed studies on these enzymes and the high-throughput screening of possible inhibitors has been limited due to the lack of suitable probes to monitor their activity. An understanding of enzyme mechanism is a vital pre-requisite to the rationale design of inhibitors. This project aims to develop new labelled analogues of undecaprenol, which will be used to study several novel antibiotic targets and provide a method for the high-throughput screening of potential antibiotic candidates.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Optimizations of Lipid II Synthesis: An Essential Glycolipid Precursor in Bacterial Cell Wall Synthesis and a Validated Antibiotic Target
脂质 II 合成的优化:细菌细胞壁合成中必需的糖脂前体和经过验证的抗生素靶点
DOI:
10.3762/bxiv.2023.49.v1
发表时间:
2023
期刊:
影响因子:
--
作者:
[Karak M]
通讯作者:
Karak M
Targeting membrane-bound bacterial cell wall precursors: a tried and true antibiotic strategy in nature and the clinic.
靶向膜结合细菌细胞壁前体:自然界和临床中经过验证的真实抗生素策略。
DOI:
10.1039/d3cc01070h
发表时间:
2023
期刊:
Chemical communications (Cambridge, England)
影响因子:
--
作者:
[Buijs NP]
通讯作者:
Buijs NP
NEW HOPE - NEW Approaches to Overcome the Problem of Antimicrobial Resistance
-
批准号:EP/Y027728/1
-
项目类别:Research Grant
-
资助金额:$161.85万
-
财政年份:2023
-
负责人:Stephen Cochrane
-
依托单位:
Interrogating the Nisin:lipid II Interaction: A Chemical Biology Approach
-
批准号:EP/V032860/1
-
项目类别:Research Grant
-
资助金额:$31.05万
-
财政年份:2022
-
负责人:Stephen Cochrane
-
依托单位:
Synthesis of novel brevicidine and laterocidine analogues active against multi-drug-resistant Gram-negative bacteria
-
批准号:EP/T01783X/1
-
项目类别:Research Grant
-
资助金额:$49.87万
-
财政年份:2020
-
负责人:Stephen Cochrane
-
依托单位:
国内基金
海外基金
VLBI天文输出和实时成图系统
-
批准号:10778721
-
项目类别:联合基金项目
-
资助金额:26.0万元
-
批准年份:2007
-
负责人:王伟华
-
依托单位: